Analyst Ratings for Questcor Pharmaceuticals (QCOR)
QCOR Rating Summary
QCOR Price Target Summary
- Highest: $52.00 (Roth Capital)
- Lowest: $26.00 (ThinkEquity)
- Average: $41.64
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$41.64 (+11.9%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/8/2013 | Favus Institutional Research | Downgrade | Sell (Buy) |
N/A (N/A) |
31.50 | 37.21 | 18.13% | Details |
| 2/21/2013 | Janney Montgomery Scott | New Coverage | Buy (N/A) |
40.00 (N/A) |
29.97 | 37.21 | 24.16% | Details |
| 2/21/2013 | Mizuho Securities | Upgrade | Buy (Neutral) |
41.00 (28.00) |
29.97 | 37.21 | 24.16% | Details |
| 10/24/2012 | Ladenburg Thalmann | Upgrade | Buy (Neutral) |
N/A (N/A) |
25.93 | 37.21 | 43.5% | Details |
| 10/9/2012 | Jefferies » Updated 11/6/2012 |
Upgrade | Buy (Hold) |
30.00 (N/A) |
20.29 | 37.21 | 83.39% | Details |
| 9/24/2012 | ThinkEquity | Downgrade | Hold (Buy) |
26.00 (58.00) |
22.26 | 37.21 | 67.16% | Details |
| 9/24/2012 | CRT Capital | Downgrade | Fairly Valued (Buy) |
N/A (N/A) |
22.26 | 37.21 | 67.16% | Details |
| 9/24/2012 | Oppenheimer | Downgrade | Perform (Outperform) |
N/A (N/A) |
22.26 | 37.21 | 67.16% | Details |
| 9/24/2012 | Piper Jaffray » Updated 10/11/2012 |
Downgrade | Neutral (Overweight) |
43.00 (N/A) |
22.26 | 37.21 | 67.16% | Details |
| 9/24/2012 | Leerink Swann | Downgrade | Market Perform (Outperform) |
35.00 (56.50) |
22.26 | 37.21 | 67.16% | Details |
| 8/6/2012 | SunTrust Robinson Humphrey | Upgrade | Buy (Neutral) |
52.00 (N/A) |
35.19 | 37.21 | 5.74% | Details |
| 7/13/2012 | BofA/Merrill Lynch » Updated 9/20/2012 |
New Coverage | Buy (N/A) |
45.00 (64.00) |
45.48 | 37.21 | -18.18% | Details |
| 4/11/2012 | Roth Capital | New Coverage | Buy (N/A) |
52.00 (N/A) |
39.32 | 37.21 | -5.37% | Details |
| 12/9/2011 | WJB Capital | New Coverage | Buy (N/A) |
50.00 (N/A) |
42.51 | 37.21 | -12.47% | Details |
| 8/9/2011 | Citadel Securities | Upgrade | Neutral (N/A) |
44.00 (N/A) |
28.65 | 37.21 | 29.88% | Details |
